Infectious agents in dilated cardiomyopathy: Genetic interactions, autoimmunity, mechanisms, and therapeutic approaches
Open Access
- 23 June 2025
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 24 (9) , 103860
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Beijing Municipality (M23008)
- National Natural Science Foundation of China (8247082356)
This publication has 143 references indexed in Scilit:
- MicroRNAs As Novel Biomarkers and Potential Therapeutic Options for Inflammatory CardiomyopathyESC Heart Failure, 2023
- The knowns and unknowns of cardiac autoimmunity in viral myocarditisReviews in Medical Virology, 2023
- Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trialEuropean Journal of Heart Failure, 2020
- An overview of the immune mechanisms of viral myocarditisReviews in Medical Virology, 2020
- Infarct-Like Myocarditis with Coronary Vasculitis and Aneurysm Formation Caused by Epstein–Barr virus InfectionESC Heart Failure, 2020
- Clinical Impact of the Presence of Macrophages in Endomyocardial Biopsies of Patients with Dilated CardiomyopathyEuropean Journal of Heart Failure, 2017
- Chromosomally Integrated Human Herpesvirus 6 in Heart Failure: Prevalence and TreatmentEuropean Journal of Heart Failure, 2014
- Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathyEuropean Journal of Immunology, 2012
- Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injuryJournal of Medical Virology, 2010
- Multicenter study on hepatitis C virus infection in patients with dilated cardiomyopathyJournal of Medical Virology, 1999